Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials Facioscapulohumeral Muscular Dystrophy (FSHD) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition:   Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention:   Drug: Losmapimod Sponsor:   Fulcrum Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Fulcrum Therapeutics Receives Orphan Drug Designation for Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) and Announces Expanded Patent Portfolio
CAMBRIDGE, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 29, 2020 Category: Pharmaceuticals Source Type: clinical trials

Evaluation of a Textile Scapula Orthosis
Conditions:   Muscular Dystrophies;   Scapular Dyskinesis;   Muscular Dystrophy, Facioscapulohumeral;   Muscle Weakness;   Muscular Weakness;   Muscular Dystrophy Interventions:   Device: Scapula orthosis assistance;   Procedure: Manual scapula assistance;   Other: No assistance;   Other: Functional Test Sponsor:   Swiss Federal Institute of Technology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2019 Category: Research Source Type: clinical trials